跳至主要内容
临床试验/CTRI/2021/10/037173
CTRI/2021/10/037173尚未招募不适用

“Immediate Effect of Mulligan Therapy on Pulmonary Function and Chest Expansion in Healthy Individualsâ€

CENTER OF REHABILITATION M S RAMAIAH HOSPITALS1 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2021年10月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
103
试验地点
1
主要终点
Pulmonary function test that is FEV1, FVC, FEV1/FVC, PEF, PIF and Chest expansion at axillary, mammary and xiphisternum

研究概览

简要总结

I Harsheeta Brijmohan Sarada, a post graduate student of physiotherapy in M S Ramaiah Medical College and doing a research titled “IMMEDIATE EFFECT OF MULLIGAN THERAPY ON PULMONARY FUNCTION AND CHEST EXPANSION IN HEALTHY INDIVIDUALS†Under the guidance of Mr. Shaswat Verma and Mrs. Akriti Gupta. This proposal has been reviewed and approved by Institutional Ethics Committee Ramaiah Medical College, which is a committee whose task it is to make sure that research participants are protected from harm.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • AGE GROUP OF 20-40 YEARS WITH BOTH THE GENDERS.

排除标准

  • •Those diagnosed with neurological findings •Thoracic surgeries.
  • •Taking regular medicines to relieve pain.
  • • Obstructive or Restrictive findings in pretest spirometer.
  • •Post COVID individuals.
  • •Chronic Orthopedic related conditions of cervical and lumbar region.

结局指标

主要结局

Pulmonary function test that is FEV1, FVC, FEV1/FVC, PEF, PIF and Chest expansion at axillary, mammary and xiphisternum

时间窗: Pulmonary function test that is FEV1, FVC, FEV1/FVC, PEF, PIF and Chest expansion at axillary, mammary and xiphisternum at baseline and after 20 minutes of therapy including Thoracic SNAGs, intercostal MWM, and MWM for Costochondral and costovertebral joints.

次要结局

  • N/A(N/A)

研究者

发起方
CENTER OF REHABILITATION M S RAMAIAH HOSPITALS
申办方类型
Research institution

研究点 (1)

Loading locations...

相似试验